Full Generic Medicine Info
Dosage/Direction for Use

Nail fungal infections
Adult: As 5% lacquer: Paint onto the affected nail 1-2 times weekly after filing and cleansing. Continue until nail has regenerated and the affected areas are cured. Treatment duration: Approx 6 months (fingernail) or 9-12 months (toenail).

Skin fungal infections
Adult: As 0.25% cream: Apply once daily for at least 2-3 weeks (up to 6 weeks for foot infections). Continue for 3-5 days after cure is attained.
Special Precautions
Childn. Pregnancy and lactation. Patient Counselling Avoid contact w/ eyes, ears, mucous membranes, and surrounding areas around the nail. Avoid using cosmetic lacquer or artificial nails.
Adverse Reactions
Hypersensitivity reactions, skin irritation, erythema, pruritus, contact dermatitis, urticaria, blister. Rarely, burning sensation, severe skin reactions, nail disorder (e.g. nail discolouration, onychoclasis, onychorrhexis).
Amorolfine, a morpholine derivative, is highly active in vitro against numerous pathogenic and opportunistic fungi. It alters fungal cell membranes by interfering w/ sterol biosynthesis.
Absorption: Systemic absorption is neglible.
Distribution: Penetrates into and diffuses through the nail plate.
Topical/Cutaneous: Store below 30°C. Protect from heat.
ATC Classification
D01AE16 - amorolfine ; Belongs to the class of other antifungals for topical use.
Disclaimer: This information is independently developed by CIMS based on amorolfine from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in